Products

APIs / APIs and intermediates for human use / Tobramycin Base

TOBRAMYCIN BASE

structure

Molecular formula:

C18H37N5O9

Molecular weigh:

467,5 (base)

CAS registry No:

32986-56-4

Presentation:

Powder

Category:

Aminoglycoside antibiotic

Application:

For human use only.
For production of pharmaceutical products.

Quality:

USP, Ph. Eur., BP.

Contents:

Not less than 97% and not more than 102%

Most commonly used drug forms:

solution for injections, powder for injections, eye drops

Packing:

0.5 BOU in aluminum can.

Re-test period:

3 years from manufacturing date.

Storage:

In a dry place, protected from light, at a temperature below 25°C.

Pharmacological action:

Tobramycin has a broad spectrum of activity against Gram-positive and Gram-negative microorganisms: P.aeruginosa; Proteus spp. (indole-positive and indole-negative), including P. mirabilis, P. morganii, P. rettgeri and P. vulgaris; E. coli; the group Klebsiella-Enterobacter-Serratia; Citrobacter spp.; Providencia spp.; Staphylococci, including S. aureus and coagulase-negative strains. It has mainly a bactericidal type of action, and the acquirement of resistance to Tobramycin advances slowly. The combinations with carbenicillin, cephalothin, cefazolin, cefoperazon and ceftriaxon have a confirmed synergetic effect in regard of P. aeruginosa.

Tobramycin is successfully used for the treatment of:

Tobramycin is also used for preparation of Tobramycin sulphate.